RBR-44kg5x招募中2 期
Efficacy and safety of intralesional use of meglumine antimoniate in the treatment of localized cutaneous leishmaniasis
Hospital Eduardo de Menezes0 个研究点开始时间: 2016年3月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 12Y 至 99Y（—）
入选标准
- •volunteers with localized cutaneous form of leishmaniasis; both sexes; with up to maximum of three lesions and area of lesions of not more than 900mm2
排除标准
- •Pretreatment with antileishmanial drugs for less than 6 months;
- •History of allergy to meglumine antimoniate; Presence of congestive heart failure or cardiac arrhythmia; Medication with potential to cause cardiac arrhythmia; Pregnancy or lactation; Creatinine above 2 mg%
研究者
相似试验
已完成
3 期
Randomized trial of local injections for cutaneousleishmaniasis caused by L. tropicaeishmania.Cutaneous leishmaniasisB55.1IRCT20081130001475N13Tehran University of Medical Sciences180
招募中
不适用
Treatment of common wartsCTRI/2017/07/009028il50
已完成
4 期
A clinical trial to study the effects of drug named Triamcinolone alone or combination of Triamcinolone and 5- Fluorouracil in patients with Keloid or hypertrophic scarsACTRN12612000546853Farrukh Aslam Khalid120
尚未招募
3 期
Effect of different strength of intralesional triamcinolone acetonide in alopecia areata.CTRI/2024/02/063138Institute of Medical Sciences BH
招募中
3 期
Comparison of efficacy of intramuscular meglumine antimoniate plus oral allopurinol with intramuscular meglumine antimoniate alone in treatment of cutaneous leishmaniasisCutaneous leishmaniasis.Cutaneous leishmaniasisB55.1IRCT20210823052264N6CMH Quetta150